Alzamend Neuro Inc. (ALZN) Narxning foydaga nisbati
Alzamend Neuro, Inc. (ALZN) immunologik usullarni va miya regeneratsiyasi uchun litiyga asoslangan ishlanmalarni birlashtirgan holda demensiyani davolashning kompleks tizimini ishlab chiqmoqda. Barqaror savdo bozori logistik uzilishlar xavfi va xalqaro patent himoyasining murakkabliklari bilan muvozanatlashgan. Biroq, biznes tor doiradagi dori vositalariga tayanadi, bu esa tashqi moliyalashtirishga bog'liqlikni yuzaga keltirmoqda. GURU.Markets platformasidagi ushbu tarixiy narxlar grafigi -0.70 qiymatini ko'rsatmoqda.
Alzamend Neuro Inc. (ALZN) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
- balans kapitallashuvi haqida ma'lumot:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning xususiy kapitalga nisbati Alzamend Neuro, Inc.|ALZN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati alzamend.com|ALZN - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Alzamend Neuro Inc.|ALZN - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzdorligi Alzamend Neuro|Oraliq qoplash koeffitsiyenti alzamend.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ALZN - Kompaniyaning sof foydasi|Sof foyda prognozi Alzamend Neuro, Inc.|ALZN - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Alzamend Neuro|ALZN - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Alzamend|ALZN - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Alzamend Neuro|ALZN - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi alzamend.com|ALZN - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Alzamend Neuro, Inc.
- kompaniyaning sotuvlari va tushumi statistikasi:
Kompaniyaning har tomonlama tahlili:Alzamend Neuro ALZN
P/E koeffitsiyenti biznesning bozor qiymatini uning sof foydasiga nisbatan aks ettirib, investitsiyalarning qoplanish muddatini o'lchaydi. Qiymatning oshishi kengayish kutayotganini bildiradi, pasayishi esa aktivning qadrsizlanganini yoki stagnatsiyani ko'rsatadi. Kompaniyaning P/E koeffitsiyentini tahlil qilish orqali investor spekulyativ narx va haqiqiy daromadlar orasidagi farqni aniqlaydi. Alzamend Neuro, Inc. (ALZN) uchun bu juda muhimdir, chunki kapitalizatsiya LiPRO texnologiyasining salohiyatiga bog'liq. Baholash bozorning Altsgeymer kasalligi uchun xavfsiz davolash usulining tijoratlashtirilishiga bo'lgan ishonchini aks ettiradi.
Muhim raqobatchilar
Narxning foydaga nisbati BIIB|P/E multiplikatori NBIX|Regencell (RGC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati axsome.com AXSM|P/E multiplikatori ACADIA Pharmaceuticals ACAD|XENE - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Narxning foydaga nisbati|CPRX (Catalyst Pharmaceuticals) - Narxning foydaga nisbati|DNLI (denalitherapeutics.com) - P/E multiplikatori|Narx-foyda multiplikatori HRMY (Harmony Biosciences Holdings, Inc.)|P/E multiplikatori BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Kapitalizatsiyaning sof foydaga nisbati|anavex.com - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CBLL (CeriBell, Inc.)|PRTA: P/E multiplikatori|Narx-foyda multiplikatori ALEC|ANNX (Annexon Biosciences Inc.) - P/E multiplikatori|omeros.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati Neurogene (NGNE)|Biznesning o‘zini qoplash muddati AC Immune SA|P/E multiplikatori VYGR (voyagertherapeutics.com)|P/E multiplikatori Neumora NMRA|Scilex Holding - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tevogen Bio Inc.|Alpha Cognition (ACOG) - Narxning foydaga nisbati|cogrx.com (CGTX) - P/E multiplikatori|Narxning foydaga nisbati Inhibikase Therapeutics|Cassava (SAVA) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Assertio Therapeutics (ASRT)|Biznesning o‘zini qoplash muddati Coya|Vistagen - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati OVID|Acumen Pharmaceuticals Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati CervoMed Inc|ATHE: P/E multiplikatori|Narx-foyda koeffitsiyenti Clene Nanomedicine|Narxning foydaga nisbati PepGen Corp|Jupiter Neurosciences (JUNS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Relmada Therapeutics, Inc. (RLMD)|ANVS - Kapitalizatsiyaning foydaga nisbati|gracetx.com - Narx-foyda koeffitsiyenti|AIFF: Narx-foyda multiplikatori|Klotho Neurosciences - P/E multiplikatori|NRSN (NeuroSense Therapeutics Ltd.) - Narx-foyda multiplikatori|Reviva Pharmaceuticals (RVPH) - Narxning foydaga nisbati|MTVA (MetaVia Inc.) - Narxning foydaga nisbati|Narxning foydaga nisbati NeurAxis, Inc|Narxning foydaga nisbati HSDT|P/E multiplikatori PASG|Biznesning o‘zini qoplash muddati Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Narx-foyda koeffitsiyenti|P/E multiplikatori Athira ATHA|Addex Therapeutics - P/E multiplikatori|CYCN - P/E multiplikatori|PTIX (Protagenic Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Pasithea (KTTA)|Narxning foydaga nisbati Cortigent|Kapitalizatsiyaning foydaga nisbati Avenue Therapeutics Inc. ATXI|Narxning foydaga nisbati brainstorm-cell.com (BCLI)|Narx-foyda koeffitsiyenti Cara Therapeutics, Inc CARA|P/E multiplikatori CHRO (chromocell.com)|Kompaniya qiymatining sof foydaga nisbati ELYM|Intra-Cellular Therapies Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Longboard Pharmaceuticals Inc|Marinus (MRNS) - Narxning foydaga nisbati|NKGN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati NeuroBo Pharmaceuticals|SAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SNPX|Trevena Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Narxning foydaga nisbati|Cerevel Therapeutics - P/E multiplikatori
